We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
Cap. Flow
+$798M
Cap. Flow %
0.98%
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$65.3M
2
AMZN icon
Amazon
AMZN
+$50M
3
TSLA icon
Tesla
TSLA
+$30.5M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$26.6M
5
EPAM icon
EPAM Systems
EPAM
+$26.3M

Sector Composition

Rank Sector Weight
1 Technology 25.54%
2 Financials 13.15%
3 Healthcare 12.95%
4 Consumer Discretionary 12.27%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HARP
2926
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$113K ﹤0.01%
1,496
FTCI icon
2927
FTC Solar
FTCI
$44.9M
$111K ﹤0.01%
1,468
-39
-3% -$3.2K
ICAD
2928
DELISTED
iCAD Inc
ICAD
$111K ﹤0.01%
15,476
-427
-3% -$3.81K
FLNT
2929
Fluent
FLNT
$120M
$110K ﹤0.01%
9,229
-140
-1% -$1.9K
FTH
2930
Faeth Therapeutics
FTH
$629M
$110K ﹤0.01%
945
+116
+14% +$17.3K
UAVS icon
2931
AgEagle Aerial Systems
UAVS
$53.9M
$110K ﹤0.01%
70
-2
-3% -$4.85K
DNTH icon
2932
Dianthus Therapeutics
DNTH
$6.09B
$109K ﹤0.01%
1,536
-11
-0.7% -$1.11K
TXMD icon
2933
TherapeuticsMD
TXMD
$24M
$106K ﹤0.01%
5,963
-137
-2% -$4.11K
ARDX icon
2934
Ardelyx
ARDX
$997M
$105K ﹤0.01%
95,165
-2,400
-2% -$2.85K
BOLT icon
2935
Bolt Biotherapeutics
BOLT
$7.78M
$104K ﹤0.01%
1,063
-10
-0.9% -$1.9K
BCEL
2936
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$104K ﹤0.01%
34,422
-537
-2% -$2.51K
CURV icon
2937
Torrid Holdings
CURV
$260M
$102K ﹤0.01%
10,302
-75
-0.7% -$1.11K
DS
2938
DELISTED
Drive Shack Inc.
DS
$102K ﹤0.01%
71,548
-1,651
-2% -$3.63K
MUFG icon
2939
Mitsubishi UFJ Financial
MUFG
$254B
$100K ﹤0.01%
18,357
+417
+2% +$2.35K
EAR
2940
DELISTED
Eargo, Inc. Common Stock
EAR
$99K ﹤0.01%
966
+53
+6% +$6.89K
FORA
2941
DELISTED
Forian
FORA
$98K ﹤0.01%
10,853
-340
-3% -$3.25K
ATCX
2942
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$96K ﹤0.01%
11,435
-559
-5% -$5.37K
SRT
2943
DELISTED
Startek Inc.
SRT
$95K ﹤0.01%
18,254
-590
-3% -$2.96K
RENT
2944
Rent the Runway
RENT
$124M
$93K ﹤0.01%
+571
New +$152K
SEEL
2945
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$93K ﹤0.01%
15
+1
+7% +$7.68K
NL icon
2946
NLI Holdings
NL
$317M
$91K ﹤0.01%
12,351
-100
-0.8% -$650
RVP icon
2947
Retractable Technologies
RVP
$20.1M
$91K ﹤0.01%
13,142
-320
-2% -$2.76K
FOA icon
2948
Finance of America Companies
FOA
$198M
$90K ﹤0.01%
2,257
-965
-30% -$45.8K
TLRY icon
2949
Tilray
TLRY
$622M
$90K ﹤0.01%
1,284
TRVN
2950
DELISTED
Trevena, Inc.
TRVN
$90K ﹤0.01%
246
-7
-3% -$3.88K

Similar funds

RhumbLine Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
  • RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
  • RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
  • RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
  • RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
  • RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
  • RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.

Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.